Second wave of late-phase Covid-19 vaccine trials unlikely to require a higher efficacy bar for FDA authorisation
Prilenia begins patient enrolment in HD drug trial in US
Prilenia Therapeutics has enrolled the first patients in a Phase III trial of pridopidine for...
Olatec Therapeutics initiates enrolment in oral drug trial for Covid-19
Olatec Therapeutics has initiated patient enrolment in a Phase II trial to analyse the safety...
Sanofi and Regeneron report eosinophilic esophagiti trial data
Sanofi and Regeneron Pharmaceuticals have reported additional positive results from Part A of a Phase...
WAKIX (pitolisant) for the Treatment of Cataplexy with Narcolepsy
WAKIX® (pitolisant) is the first and only non-scheduled medication indicated for the treatment of cataplexy...
Lilly and Boehringer report positive outcomes in heart failure trial
Eli Lilly and Boehringer Ingelheim have reported that new exploratory sub-analysis data from the EMPEROR-Reduced...
Dicerna’s nedosiran achieves urinary oxalate normalisation in PH trial
Dicerna Pharmaceuticals has reported positive interim data from its ongoing PHYOX3 trial of investigational drug candidate,...
Interim results of the SOLIDARITY trial failed to show efficacy of repurposed drugs in mortality of hospitalized Covid-19 patients
The World Health Organization’s Phase II/III SOLIDARITY trial for COVID-19 is currently the world’s largest...
Positive data for Amylyx’s AMX0035 strengthen its position to enter ALS market
On October 16, Amylyx announced that AMX0035, its amyotrophic lateral sclerosis (ALS) pipeline drug, showed...
Pfizer’s 20vPnC boosts immune response in pneumococcal disease trial
Pfizer has reported full analysis data from one of its Phase III trials of its...